Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Nurix Therapeutics IncNRIX | $15.64 | Strong Buy | $45.00 | +187.72% | 17 hours ago | |
Analyst RankingTop 23% #1207 out of 5292 analysts Average Return+8.16% Win Rate38%23 out of 60 Risk vs RewardPoor Good Analyst ColorJefferies's Roger Song raised their price target on Nurix Therapeutics (NASDAQ: NRIX) by 9.8% from $41 to $45 on 2026/06/08. The analyst maintained their Strong Buy rating on the stock. Song said their price target hike was catalyzed when Nurix Therapeutics' annoucemed a global co-development and co-commercialization deal with Roche for bexobrutideg. The analyst called the the deal "validation of the degrader class and bexobrutideg's differentiation, with signals of durability, CNS penetration, and a favorable safety profile." | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.